期刊文献+

骨桥蛋白特异性短发夹RNA抑制大鼠血管平滑肌细胞增殖 被引量:3

Effect of Osteopontin-specific Small Hairpin RNA on Proliferation of Vascular Smooth Muscle Cells of Rats
下载PDF
导出
摘要 目的应用特异性短发夹RNA(shRNA)抑制血管平滑肌细胞骨桥蛋白基因表达,观察其对体外培养的血管平滑肌细胞增殖的影响。方法根据大鼠骨桥蛋白基因设计靶序列,采用体外转录方法获取shRNA,以此转染血管平滑肌细胞,采用逆转录-聚合酶链反应、Western blot等方法检测骨桥蛋白mRNA和蛋白的表达;用MTT法检测shRNA对血管平滑肌细胞增殖的影响。结果与未转染特异性shRNA细胞相比,转染shRNA的细胞中骨桥蛋白mRNA、蛋白表达量均明显降低,抑制率分别为(76.3±3.4)%和(68.7±4.6)%。血管平滑肌细胞的增殖也受到明显的抑制。结论设计的靶序列能有效沉默血管平滑肌细胞骨桥蛋白基因的表达,为进一步构建载体和体内研究奠定了基础。 Objective To study the inhibitory effects of osteopontin(OPN)-specific small hairpin RNA(shRNA) on the expression of osteopontin(OPN) and its effect on the proliferation of in vitro cultured vascular smooth muscle cells in rats.Methods One target sequence was designed according to rats OPN sequence information from Dharmacon siRNA Design Center and shRNA was transcribed in vitro.The shRNA was transfected into vascular smooth muscle cells.Semi-quantitative polymerase chain reaction and Western blot were carried out to detect the expression of OPN mRNA and protein respectively.The cell proliferation was assayed by MTT.Results Compared with the blank control cells,the expression of OPN mRNA and protein in the cells transfected with shRNA was significantly decreased with the inhibition rate being(76.3±3.4)% and((68.7)±4.6)% respectively.The proliferation of vascular smooth muscle cells was inhibited obviously when OPN gene expression was knocked down by RNA interference(RNAi).Conclusion The expression of OPN gene can be efficiently inhibited in vitro by RNAi technique.These results are informative for further vector construction and study in vivo.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第6期734-736,739,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 骨桥蛋白 RNA干扰 基因表达 细胞增殖 osteopontin RNA interference gene expression proliferation
  • 相关文献

参考文献9

  • 1[1]HARBORTH J,ELBASHIR S M,BECHERT K,et al.Identification of essential genes in cultured mammalian cells using small interfering RNAs[J].J Cell Science,2001,114(Pt 24):4557-4565.
  • 2[2]BRUMMELKAMP T R,BERNARDS R,AGAMI R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553.
  • 3[3]BAUTERS C,ISNER J M.The biology of restenosis[J].Prog Cardiovasc Dis,1997,40(2):107-116.
  • 4[4]SHANAHAN C M,WEISSBERG P L,METEALFE J C.Isolation of gene markers of differentiated and proferating vascular smooth muscle cells[J].Circ Res,1993,73(1):193-204.
  • 5[5]HULTGARDH-NILSSON A,LOVDAH C,BLOMGREN K,et al.Expression of phenotype and proliferation related genes in rat aortic smooth muscle cells in primary culture[J].Cardiovasc Res,1997,34(2):418-430.
  • 6张永钢,韩梅,温进坤,程云会,刘智敏.抗骨桥蛋白抗体防治内皮剥脱术后血管狭窄的实验研究[J].河北医科大学学报,2004,25(4):222-223. 被引量:1
  • 7[7]LEE N S,DOHJIMA T,BAUER G,et al.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells[J].Nat Biotechnol,2002,19(5):500-505.
  • 8[8]PADDISON P J,CAUDY A A,HANNON G J.Stable suppression of gene expression by RNAi in mammalian cells[J].Proc Natl Acad Sci USA,2002,99(3):1443-1438.
  • 9[9]YU J Y,DERUITER S L,TURNER D L.RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci USA,2002,99(9):6047-6052.

同被引文献40

  • 1韩梅,张永钢,温进坤.抗骨桥蛋白抗体抑制血管内膜增生的实验研究[J].中国病理生理杂志,2006,22(3):477-480. 被引量:9
  • 2Giachelli CM, Bae N, Almeida M, et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest, 1993,92 : 1686-1696.
  • 3Takahashi K, Takahashi F, Tanabe KK, et al. The carboxylteminal fragment of osteopontln suppresses arginine-glycineasparatic acid-dependent cell adhesion. Biochem Mol Biol Int, 1998,46 : 1081-1092.
  • 4Helluin O, Chan C, Vilaire G, et al. The activation state of αvβ3 regulates platelet and lymphocyte adhesion to intact and thrombin- cleavaged osteopontin. J Biol Chem, 2000,275 : 18337-18343.
  • 5Kart hikeyan G, Bhargava B. Prevention of restenosis after coronary angioplasty. Curr Opin Cardiol,2004,19:500-509.
  • 6Hayden MR, Tyagi SC. Arterial vascular remodeling: the endothelial cell's central role. Mo Med, 1998,95:213-217.
  • 7Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventltial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation ,2002,105:2504-2511.
  • 8Ohmori R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis,2003,170:333-337.
  • 9Suezawa C, Kusachi S, Murakami T, et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med,2005, 145:33-40.
  • 10Panda D, Kundu GC, Lee BI, et al. Potential roles of osteopontin and αvβ3 integrin in the development of coronary artery restertosis after angioplasty. Proc Natl Acad Sci USA, 1997,94:9308-9313.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部